தாள செவிவழி ஸ்டிம்யுலேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தாள செவிவழி ஸ்டிம்யுலேஶந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தாள செவிவழி ஸ்டிம்யுலேஶந் Today - Breaking & Trending Today

MedRhythms Closes $25M Series B Funding to Advance Digital Therapeutics Platform


MedRhythms Closes $25M Series B Funding to Advance Digital Therapeutics Platform
MedRhythms announces the closing of a $25 million Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates. It has raised a total of $34 million in gross proceeds from private financings since inception.
The proceeds from the Series B financing will enable MedRhythms to expand its team and key corporate functions as the company commercializes its flagship product for chronic stroke survivors with walking deficits and advances its digital therapeutics pipeline.
Digital Therapeutics System
The MedRhythms Digital Therapeutics System is designed to use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease. ....

United States , Brian Harris , Chris Harris , Stephen Bruso , Werth Family Investment Associates , Drug Administration , Morningside Ventures , Advantage Capital , Werth Family Investment , Medrhythms Digital Therapeutics System , Rhythmic Auditory Stimulation , Chief Executive Officer , Breakthrough Device , Massachusetts General Hospital , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஹாரிஸ் , கிறிஸ் ஹாரிஸ் , ஸ்டீபன் புருசோ , வெர்த் குடும்பம் முதலீடு கூட்டாளிகள் , காலை முயற்சிகள் , வெர்த் குடும்பம் முதலீடு , தாள செவிவழி ஸ்டிம்யுலேஶந் , தலைமை நிர்வாகி அதிகாரி , திருப்புமுனை சாதனம் , மாசசூசெட்ஸ் ஜநரல் மருத்துவமனை ,

Trial of Rhythmic Sound Therapy to Aid Walking in MS Launching

MedRhythms and Massachusetts General Hospital Launch Study of Gait Asset for Multiple Sclerosis


MedRhythms and Massachusetts General Hospital Launch Study of Gait Asset for Multiple Sclerosis
MedRhythms announces the launch of a clinical trial, in collaboration with Massachusetts General Hospital (MGH), that will study MR-004, MedRhythms’ multiple sclerosis (MS) asset.
The trial was funded by the National Multiple Sclerosis Society, aims to study the impacts of Rhythmic Auditory Stimulation on MS walking impairments. It expands on the research that is being conducted with MR-004 in a clinical trial with Cleveland Clinic that was announced in 2020.
The trial will be led at MGH by Co-Principal Investigators, Dr. Eric Klawiter and Dr. Ron Hirschberg, and will be a randomized crossover trial looking at the impacts of MR-004, a digital therapeutic that digitizes Rhythmic Auditory Stimulation, on functional outcomes such as gait speed as well as neuroimaging compared to standard of care, a media release from MedRhythms explains. ....

United States , Brian Harris , Eric Klawiter , Ron Hirschberg , National Multiple Sclerosis Society , Massachusetts General Hospital , Rhythmic Auditory Stimulation , Cleveland Clinic , Co Principal Investigators , Multiple Sclerosis , Neuromyelitis Optica Unit , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஹாரிஸ் , ரோன் ிர்ஸ்ச்பேர்க் , தேசிய பல ஸ்க்லரோசிஸ் சமூகம் , மாசசூசெட்ஸ் ஜநரல் மருத்துவமனை , தாள செவிவழி ஸ்டிம்யுலேஶந் , கிளீவ்லேண்ட் சிகிச்சையகம் , இணை ப்ரிந்ஸிபல் புலனாய்வாளர்கள் , பல ஸ்க்லரோசிஸ் ,